Otsuka Holdings Co., Ltd.

4578.T
Drug Manufacturers - General
2026/02/13 Updated
Market Cap: $34.1B (¥5.2T)
Stock Price: $64.56 (¥9,871)
Exchange Rate: 1 USD = ¥152.91

Notice of Decision Regarding Share Buyback and Cancellation of Treasury Stock

Otsuka Holdings plans to acquire up to 7,000,000 shares of treasury stock (ceiling, 1.33% of total issued shares) for a maximum of 50 billion yen from February 16, 2026 to December 23, 2026, with cancellation scheduled on January 29, 2027.

Importance:
Page Updated: February 13, 2026
IR Disclosure Date: February 13, 2026

Key Figures

  • Acquisition Limit: 7,000,000 shares (1.33% of total issued shares)
  • Acquisition Price Cap: 50 billion yen
  • Acquisition Period: From February 16, 2026 to December 23, 2026

AI要約

Overview of Share Buyback

Otsuka Holdings Co., Ltd. has resolved to acquire treasury stock based on Article 459, Paragraph 1 of the Companies Act with the aim of improving capital efficiency and shareholder returns. The target shares are the Company's common stock, with an acquisition limit of 7,000,000 shares (1.33% of the total issued shares) and a total acquisition price cap of 50 billion yen. The acquisition period is from February 16, 2026 to December 23, 2026.

Regarding Cancellation of Treasury Stock

The acquired treasury stock will be cancelled in accordance with Article 178 of the Companies Act, with the scheduled cancellation date set for January 29, 2027. The cancellation will target all the acquired treasury stock shares. As of December 31, 2025, the number of treasury stock shares held was 14,857,548 shares, and the total issued shares (excluding treasury stock) was 528,131,369 shares.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.